Skip to main content
SpringerLink
Log in

Active Surveillance Cultures for MRSA, VRE, Multidrug-Resistant Gram-Negatives

  • Chapter
  • First Online:
Infection Prevention

  • 2166 Accesses

Abstract

Active surveillance [AS] is increasingly used as an infection control measure to control the transmission of multidrug-resistant [MDR] bacteria; however, studies on their efficacy have been conflicting. AS identifies patients colonized with MDR pathogens who act as a source for transmission to other patients. In this chapter, we discuss the strengths and drawbacks of studies on AS for control of spread of methicillin-resistant Staphylococcus aureus [MRSA], vancomycin-resistant Enterococcus [VRE], and MDR-Gram-negative organisms [MDR-GNs] and point out the factors which can influence the outcomes of AS programs. Furthermore, microbiologic and molecular methods used and patient populations targeted in AS programs are also reviewed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Weiner LM, Webb AK, Limbago B, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the national healthcare safety network at the centers for disease control and prevention, 2011–2014. Infect Control Hosp Epidemiol. 2016;37(11):1288–301.

    Article  PubMed  Google Scholar 

  2. Cosgrove SE. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis. 2006;42(Suppl 2):S82–9.

    Article  PubMed  Google Scholar 

  3. DiazGranados CA, Zimmer SM, Klein M, Jernigan JA. Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis. Clin Infect Dis. 2005;41(3):327–33.

    Article  PubMed  Google Scholar 

  4. Huang SS, Rifas-Shiman SL, Pottinger JM, et al. Improving the assessment of vancomycin-resistant enterococci by routine screening. J Infect Dis. 2007;195(3):339–46.

    Article  CAS  PubMed  Google Scholar 

  5. Ben-Ami R, Schwaber MJ, Navon-Venezia S, et al. Influx of extended-spectrum beta-lactamase-producing enterobacteriaceae into the hospital. Clin Infect Dis. 2006;42(7):925–34.

    Article  CAS  PubMed  Google Scholar 

  6. Calfee DP, Giannetta ET, Durbin LJ, Germanson TP, Farr BM. Control of endemic vancomycin-resistant enterococcus among inpatients at a university hospital. Clin Infect Dis. 2003;37(3):326–32.

    Article  PubMed  Google Scholar 

  7. Muto CA, Jernigan JA, Ostrowsky BE, et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect Control Hosp Epidemiol. 2003;24(5):362–86.

    Article  PubMed  Google Scholar 

  8. Elizaga ML, Weinstein RA, Hayden MK. Patients in long-term care facilities: a reservoir for vancomycin-resistant enterococci. Clin Infect Dis. 2002;34(4):441–6.

    Article  PubMed  Google Scholar 

  9. Polgreen PM, Beekmann SE, Chen YY, et al. Epidemiology of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus in a rural state. Infect Control Hosp Epidemiol. 2006;27(3):252–6.

    Article  PubMed  Google Scholar 

  10. Marquez P, Terashita D, Dassey D, Mascola L. Population-based incidence of carbapenem-resistant Klebsiella pneumoniae along the continuum of care, Los Angeles County. Infect Control Hosp Epidemiol. 2013;34(2):144–50.

    Article  PubMed  Google Scholar 

  11. Kochar S, Sheard T, Sharma R, et al. Success of an infection control program to reduce the spread of carbapenem-resistant Klebsiella pneumoniae. Infect Control Hosp Epidemiol. 2009;30(5):447–52.

    Article  PubMed  Google Scholar 

  12. Thiebaut AC, Arlet G, Andremont A, et al. Variability of intestinal colonization with third-generation cephalosporin-resistant Enterobacteriaceae and antibiotic use in intensive care units. J Antimicrob Chemother. 2012;67(6):1525–36.

    Article  CAS  PubMed  Google Scholar 

  13. Ostrowsky BE, Trick WE, Sohn AH, et al. Control of vancomycin-resistant enterococcus in health care facilities in a region. N Engl J Med. 2001;344(19):1427–33.

    Article  CAS  PubMed  Google Scholar 

  14. Harbarth S, Fankhauser C, Schrenzel J, et al. Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. JAMA. 2008;299(10):1149–57.

    Article  CAS  PubMed  Google Scholar 

  15. McGinigle KL, Gourlay ML, Buchanan IB. The use of active surveillance cultures in adult intensive care units to reduce methicillin-resistant Staphylococcus aureus-related morbidity, mortality, and costs: a systematic review. Clin Infect Dis. 2008;46(11):1717–25.

    Article  PubMed  Google Scholar 

  16. Tschudin-Sutter S, Frei R, Dangel M, Stranden A, Widmer AF. Rate of transmission of extended-spectrum beta-lactamase-producing enterobacteriaceae without contact isolation. Clin Infect Dis. 2012;55(11):1505–11.

    Article  PubMed  Google Scholar 

  17. Price CS, Paule S, Noskin GA, Peterson LR. Active surveillance reduces the incidence of vancomycin-resistant enterococcal bacteremia. Clin Infect Dis. 2003;37(7):921–8.

    Article  PubMed  Google Scholar 

  18. Souweine B, Traore O, Aublet-Cuvelier B, et al. Role of infection control measures in limiting morbidity associated with multi-resistant organisms in critically ill patients. J Hosp Infect. 2000;45(2):107–16.

    Article  CAS  PubMed  Google Scholar 

  19. Almyroudis NG, Osawa R, Samonis G, et al. Discontinuation of systematic surveillance and contact precautions for Vancomycin-Resistant Enterococcus (VRE) and its impact on the incidence of VRE faecium bacteremia in patients with hematologic malignancies. Infect Control Hosp Epidemiol. 2016;37(4):398–403.

    Article  PubMed  Google Scholar 

  20. Huang SS, Yokoe DS, Hinrichsen VL, et al. Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis. 2006;43(8):971–8.

    Article  PubMed  Google Scholar 

  21. Noorani HZ, Adams E, Glick S, Weber S, Belinson S, Aronson N. Screening for Methicillin-Resistant Staphylococcus aureus (MRSA): future research needs: identification of future research needs from comparative effectiveness review no. 102. Rockville: Agency for Healthcare Research and Quality (US); 2013.

    Google Scholar 

  22. Jain R, Kralovic SM, Evans ME, et al. Veterans affairs initiative to prevent methicillin-resistant Staphylococcus aureus infections. N Engl J Med. 2011;364(15):1419–30.

    Article  CAS  PubMed  Google Scholar 

  23. Huskins WC, Huckabee CM, O'Grady NP, et al. Intervention to reduce transmission of resistant bacteria in intensive care. N Engl J Med. 2011;364(15):1407–18.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Huang SS, Septimus E, Kleinman K, et al. Targeted versus universal decolonization to prevent ICU infection. N Engl J Med. 2013;368(24):2255–65.

    Article  CAS  PubMed  Google Scholar 

  25. Derde LP, Cooper BS, Goossens H, et al. Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial. Lancet Infect Dis. 2014;14(1):31–9.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Tacconelli E, De Angelis G, de Waure C, Cataldo MA, La Torre G, Cauda R. Rapid screening tests for meticillin-resistant Staphylococcus aureus at hospital admission: systematic review and meta-analysis. Lancet Infect Dis. 2009;9(9):546–54.

    Article  PubMed  Google Scholar 

  27. Rupp ME, Marion N, Fey PD, et al. Outbreak of vancomycin-resistant enterococcus faecium in a neonatal intensive care unit. Infect Control Hosp Epidemiol. 2001;22(5):301–3.

    Article  CAS  PubMed  Google Scholar 

  28. Byers KE, Anglim AM, Anneski CJ, et al. A hospital epidemic of vancomycin-resistant enterococcus: risk factors and control. Infect Control Hosp Epidemiol. 2001;22(3):140–7.

    Article  CAS  PubMed  Google Scholar 

  29. Hanna H, Umphrey J, Tarrand J, Mendoza M, Raad I. Management of an outbreak of vancomycin-resistant enterococci in the medical intensive care unit of a cancer center. Infect Control Hosp Epidemiol. 2001;22(4):217–9.

    Article  CAS  PubMed  Google Scholar 

  30. Mascini EM, Troelstra A, Beitsma M, et al. Genotyping and preemptive isolation to control an outbreak of vancomycin-resistant enterococcus faecium. Clin Infect Dis. 2006;42(6):739–46.

    Article  CAS  PubMed  Google Scholar 

  31. Munoz-Price LS, Hayden MK, Lolans K, et al. Successful control of an outbreak of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae at a long-term acute care hospital. Infect Control Hosp Epidemiol. 2010;31(4):341–7.

    Article  PubMed  Google Scholar 

  32. Simor AE, Lee M, Vearncombe M, et al. An outbreak due to multiresistant Acinetobacter baumannii in a burn unit: risk factors for acquisition and management. Infect Control Hosp Epidemiol. 2002;23(5):261–7.

    Article  PubMed  Google Scholar 

  33. Piagnerelli M, Kennes B, Brogniez Y, Deplano A, Govaerts D. Outbreak of nosocomial multidrug-resistant Enterobacter aerogenes in a geriatric unit: failure of isolation contact, analysis of risk factors, and use of pulsed-field gel electrophoresis. Infect Control Hosp Epidemiol. 2000;21(10):651–3.

    Article  CAS  PubMed  Google Scholar 

  34. Giuffre M, Cipolla D, Bonura C, et al. Outbreak of colonizations by extended-spectrum beta-lactamase-producing Escherichia coli sequence type 131 in a neonatal intensive care unit, Italy. Antimicrob Resist Infect Control. 2013;2(1):8.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Ciofi Degli Atti M, Bernaschi P, Carletti M, et al. An outbreak of extremely drug-resistant Pseudomonas aeruginosa in a tertiary care pediatric hospital in Italy. BMC Infect Dis. 2014:14–494.

    Google Scholar 

  36. Munoz-Price LS, Quinn JP. Deconstructing the infection control bundles for the containment of carbapenem-resistant Enterobacteriaceae. Curr Opin Infect Dis. 2013;26(4):378–87.

    Article  PubMed  Google Scholar 

  37. Yakupogullari Y, Otlu B, Dogukan M, et al. Investigation of a nosocomial outbreak by alginate-producing pan-antibiotic-resistant Pseudomonas aeruginosa. Am J Infect Control. 2008;36(10):e13–8.

    Article  PubMed  Google Scholar 

  38. Gardam MA, Burrows LL, Kus JV, et al. Is surveillance for multidrug-resistant enterobacteriaceae an effective infection control strategy in the absence of an outbreak? J Infect Dis. 2002;186(12):1754–60.

    Article  PubMed  Google Scholar 

  39. Zahar JR, Poirel L, Dupont C, Fortineau N, Nassif X, Nordmann P. About the usefulness of contact precautions for carriers of extended-spectrum beta-lactamase-producing Escherichia coli. BMC Infect Dis. 2015;15:512.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Swaminathan M, Sharma S, Poliansky Blash S, et al. Prevalence and risk factors for acquisition of carbapenem-resistant Enterobacteriaceae in the setting of endemicity. Infect Control Hosp Epidemiol. 2013;34(8):809–17.

    Article  PubMed  Google Scholar 

  41. Schwaber MJ, Carmeli Y. An ongoing national intervention to contain the spread of carbapenem-resistant enterobacteriaceae. Clin Infect Dis. 2014;58(5):697–703.

    Article  PubMed  Google Scholar 

  42. Apisarnthanarak A, Pinitchai U, Thongphubeth K, et al. A multifaceted intervention to reduce pandrug-resistant Acinetobacter baumannii colonization and infection in 3 intensive care units in a Thai tertiary care center: a 3-year study. Clin Infect Dis. 2008;47(6):760–7.

    Article  PubMed  Google Scholar 

  43. Manian FA, Senkel D, Zack J, Meyer L. Routine screening for methicillin-resistant Staphylococcus aureus among patients newly admitted to an acute rehabilitation unit. Infect Control Hosp Epidemiol. 2002;23(9):516–9.

    Article  PubMed  Google Scholar 

  44. Sanford MD, Widmer AF, Bale MJ, Jones RN, Wenzel RP. Efficient detection and long-term persistence of the carriage of methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 1994;19(6):1123–8.

    Article  CAS  PubMed  Google Scholar 

  45. Perry JD, Davies A, Butterworth LA, Hopley AL, Nicholson A, Gould FK. Development and evaluation of a chromogenic agar medium for methicillin-resistant Staphylococcus aureus. J Clin Microbiol. 2004;42(10):4519–23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Huletsky A, Lebel P, Picard FJ, et al. Identification of methicillin-resistant Staphylococcus aureus carriage in less than 1 hour during a hospital surveillance program. Clin Infect Dis. 2005;40(7):976–81.

    Article  PubMed  Google Scholar 

  47. Faron ML, Ledeboer NA, Buchan BW. Resistance mechanisms, epidemiology, and approaches to screening for vancomycin-resistant enterococcus in the health care setting. J Clin Microbiol. 2016;54(10):2436–47.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Usacheva EA, Ginocchio CC, Morgan M, et al. Prospective, multicenter evaluation of the BD GeneOhm VanR assay for direct, rapid detection of vancomycin-resistant enterococcus species in perianal and rectal specimens. Am J Clin Pathol. 2010;134(2):219–26.

    Article  PubMed  Google Scholar 

  49. Shadel BN, Puzniak LA, Gillespie KN, Lawrence SJ, Kollef M, Mundy LM. Surveillance for vancomycin-resistant enterococci: type, rates, costs, and implications. Infect Control Hosp Epidemiol. 2006;27(10):1068–75.

    Article  PubMed  Google Scholar 

  50. Humphreys H. Controlling the spread of vancomycin-resistant enterococci. Is active screening worthwhile? J Hosp Infect. 2014;88(4):191–8.

    Article  CAS  PubMed  Google Scholar 

  51. Wijesuriya TM, Perry P, Pryce T, et al. Low vancomycin MICs and fecal densities reduce the sensitivity of screening methods for vancomycin resistance in enterococci. J Clin Microbiol. 2014;52(8):2829–33.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Nordmann P, Gniadkowski M, Giske CG, et al. Identification and screening of carbapenemase-producing Enterobacteriaceae. Clin Microbiol Infect. 2012;18(5):432–8.

    Article  CAS  PubMed  Google Scholar 

  53. Nordmann P, Poirel L. Strategies for identification of carbapenemase-producing Enterobacteriaceae. J Antimicrob Chemother. 2013;68(3):487–9.

    Article  CAS  PubMed  Google Scholar 

  54. Hacek DM, Bednarz P, Noskin GA, Zembower T, Peterson LR. Yield of vancomycin-resistant enterococci and multidrug-resistant Enterobacteriaceae from stools submitted for Clostridium difficile testing compared to results from a focused surveillance program. J Clin Microbiol. 2001;39(3):1152–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Marchaim D, Navon-Venezia S, Schwartz D, et al. Surveillance cultures and duration of carriage of multidrug-resistant Acinetobacter baumannii. J Clin Microbiol. 2007;45(5):1551–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Grohs P, Podglajen I, Guerot E, et al. Assessment of five screening strategies for optimal detection of carriers of third-generation cephalosporin-resistant Enterobacteriaceae in intensive care units using daily sampling. Clin Microbiol Infect. 2014;20(11):O879–86.

    Article  CAS  PubMed  Google Scholar 

  57. Abbott IJ, Jenney AW, Spelman DW, et al. Active surveillance for multidrug-resistant gram-negative bacteria in the intensive care unit. Pathology. 2015;47(6):575–9.

    Article  CAS  PubMed  Google Scholar 

  58. Tato M, Ruiz-Garbajosa P, Traczewski M, et al. Multisite evaluation of Cepheid Xpert Carba-R assay for detection of Carbapenemase-producing organisms in rectal swabs. J Clin Microbiol. 2016;54(7):1814–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Harbarth S, Sax H, Fankhauser-Rodriguez C, Schrenzel J, Agostinho A, Pittet D. Evaluating the probability of previously unknown carriage of MRSA at hospital admission. Am J Med. 2006;119(3):275 e215–23.

    Article  Google Scholar 

  60. Zimmerman FS, Assous MV, Bdolah-Abram T, Lachish T, Yinnon AM, Wiener-Well Y. Duration of carriage of carbapenem-resistant Enterobacteriaceae following hospital discharge. Am J Infect Control. 2013;41(3):190–4.

    Article  PubMed  Google Scholar 

  61. Ghosh A, Jiao L, Al-Mutawa F, et al. Value of an active surveillance policy to document clearance of meticillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci amongst inpatients with prolonged admissions. J Hosp Infect. 2014;88(4):230–3.

    Article  CAS  PubMed  Google Scholar 

  62. Siegel JD, Rhinehart E, Jackson M, Chiarello L. Healthcare infection control practices advisory C. Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control. 2007;35(10 Suppl 2):S165–93.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Infectious Diseases, Harper University Hospital, Detroit Medical Center/Wayne State University, 3990 John R, Detroit, MI, 48201, USA

    Amar Krishna & Teena Chopra

Authors
  1. Amar Krishna
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Teena Chopra
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Amar Krishna .

Editor information

Editors and Affiliations

  1. VCUHS Epidemiology and Infection Control, North Hospital, Richmond, Virginia, USA

    Gonzalo Bearman

  2. Medical College of Wisconsin, Milwaukee, Wisconsin, USA

    Silvia Munoz-Price

  3. University of Maryland, Baltimore, Maryland, USA

    Daniel J. Morgan

  4. Department of Medical Affairs and Division of Infectious Diseases, Cedars-Sinai Health System, Los Angeles, California, USA

    Rekha K. Murthy

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Krishna, A., Chopra, T. (2018). Active Surveillance Cultures for MRSA, VRE, Multidrug-Resistant Gram-Negatives. In: Bearman, G., Munoz-Price, S., Morgan, D., Murthy, R. (eds) Infection Prevention. Springer, Cham. https://doi.org/10.1007/978-3-319-60980-5_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-60980-5_15

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-60978-2

  • Online ISBN: 978-3-319-60980-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation